Table 2.
EBC miRNAs with potential as biomarkers in lung cancer.
| Cancer vs. HDs | Type of Cancer: AD vs. SCC | Stage I-III vs. Stage IV | |||
|---|---|---|---|---|---|
| EBC miRNAs | Combined Model | EBC miRNAs | Combined Model | EBC miRNAs | Combined Model |
| miR-6777-5p | AUC: 0.837 | miR-8075 | AUC: 0.981 | miR-602 | AUC: 0.935 |
| miR-4507 | Specificity: 0.75 | miR-4529-3p | Specificity: 1 | miR-551b-5p | Specificity: 0.88 |
| miR-451a | Sensitivity: 0.81 | miR-7704 | Sensitivity: 0.88 | miR-1272 | Sensitivity: 0.91 |
| Invasion vs. No Invasion | Prognosis 500 days: Deceased vs. Alive | ||||
| EBC miRNAs | Combined Model | EBC miRNAs | Combined Model | ||
| miR-6803-5p | AUC: 1 | miR-877-5p | AUC: 1 | ||
| miR-548x-3p | Specificity: 1 | miR-6777-5p | Specificity: 1 | ||
| miR-1272 | Sensitivity: 1 | miR-6780a-5p | Sensitivity: 1 | ||